Skip to main content
Risk Assessment and Monitoring of Chronic Pulmonary Hypertension in Premature Infants.
50 Years Ago in TheJournalofPediatrics: The Diagnostic Value of Gamma Glutamyl Transpeptidase in Children and Adolescents with Liver Disease.
Morbidity of Persistent Pulmonary Hypertension of the Newborn in the First Year of Life.
Lack of Equipoise in the PDA-TOLERATE Trial: A Comparison of Eligible Infants Enrolled in the Trial and Those Treated Outside the Trial.
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course.
Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium.
Genetic disorders of lung development.
Large Scale Next Generation Sequencing and Newborn Screening: Are We Ready?
50 Years Ago in The Journal of Pediatrics: Radiologic Findings in the Lungs of Premature Infants.